NCT05709912

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

Randomized Controlled Trial of a Psychosocial Mobile Application (App) to Promote Coping for Caregivers of Patients Receiving Hematopoietic Cell Transplantation (HCT)

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 120 (estimated)
• Sponsor: Massachusetts General Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this research study is to determine whether a self-administered, psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT).

Detailed description

This is a randomized clinical trial to determine whether a psychosocial mobile application (CARE app) is effective at improving the quality of life and experience of caregivers of patients receiving hematopoietic stem cell transplantation (HCT). The CARE app was developed with the goal of addressing the needs of caregivers of HCT recipients. Participants will be randomized into one of two study groups: CARE app plus Usual Care versus Usual Care. Participation in this study is expected to last up to 100 days after HCT. It is expected that about 120 people will take part in this research study. The Leukemia and Lymphoma Society is supporting this research by providing funding.

Conditions

• Bone Marrow Transplant Complications
• Hematologic Malignancy

Interventions

Type	Name	Description
BEHAVIORAL	CARE Application	Self-administered, psychosocial mobile application comprised of 5 learning modules.
BEHAVIORAL	Usual Care	Meeting with transplant social worker prior to HCT, consistent with standard-of-care.

Timeline

• Start date: 2023-07-01
• Primary completion: 2024-12-01
• Completion: 2026-12-01
• First posted: 2023-02-02
• Last updated: 2025-11-18

Locations

1 site across 1 country: United States